Search results
BioNTech gets $145 million funding for African vaccine plants
Reuters via AOL· 15 hours agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
Reuters· 15 hours agoCOVID-19 vaccine maker BioNTech won up to $145 million in funding from a global coalition against...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 4 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
Endpoints News· 2 days agoAs BioNTech’s pipeline tilts back toward oncology, the German biotech is once again tapping a young...
Germany's military to drop mandatory Covid-19 vaccination requirement
dpa international via Yahoo News· 15 hours agoSoldiers in the German armed forces will no longer be required to present proof of coronavirus...
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock. This is an increase ...
BioNTech pays $25M upfront to strengthen ADC bond with China's MediLink
FierceBiotech· 2 days agoAfter penning a couple of antibody-drug conjugate (ADC) deals in 2023, BioNTech has returned to MediLink Therapeutics to further pad out its portfolio. This time,
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
FOX 4 Kansas City· 3 days agoMediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "< ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 6 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...